Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3606950

CCCCN(CCCC)[P+](N(C)C)(N(C)C)N(C)C.[Cl-]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.36
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA9 Q16790 3/20 0.34
ALDH1A1 P00352 1/20 0.34
ALDH2 P05091 1/20 0.34
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP8 P22894 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3605614 0.97 DNM1 (0.35) DNM1CA12CA1CA9ALDH1A1
Bromide SCHEMBL7669293 0.95 DNM1 (0.36) DNM1CA12CA1CA9ALDH1A1
Hydrochloric Acid SCHEMBL1357309 0.90 DNM1 (0.50) DNM1CA12CA1CA9CA2
Hydrochloric Acid SCHEMBL3593887 0.90 DNM1 (0.50) DNM1CA12CA1CA9CA2
Hydrochloric Acid SCHEMBL3592047 0.86 CA12 (0.39) DNM1CA12CA1CA9ALDH1A1
Bromide SCHEMBL1357737 0.85 DNM1 (0.50) DNM1CA12CA1CA9ALDH1A1
Bromide SCHEMBL7624606 0.85 DNM1 (0.50) DNM1CA12CA1CA9ALDH1A1
Hydrochloric Acid SCHEMBL3598152 0.83
Iodide SCHEMBL6151762 0.80 CA12 (0.39) DNM1CA12CA1CA9ALDH1A1
Bromide SCHEMBL6151479 0.80 CA12 (0.39) DNM1CA12CA1CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides BAYER CROPSCIENCE AG (DE) 2009-12-10 US claimed
EP-1928839-B1 METHOD FOR THE PRODUCTION OF 5-FLUORO-1,3-DIALKYL-1H-PYRAZOL-4-CARBONYL FLUORIDES BAYER CROPSCIENCE AG (DE) 2008-12-31 EP claimed
EP-0958052-B1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS CLARIANT GMBH (DE) 2002-12-04 EP claimed
JP-2001508359-A 2001-06-26 JP claimed
US-6103659-A Catalyst comprising an amidophosphonium salt for halex reactions AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2000-08-15 US claimed
EP-0958052-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS Aventis Research & Technologies GmbH & Co. KG (DE) 1999-11-24 EP claimed
WO-1998032532-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-07-30 WO claimed
US-7714144-B2 5-chloro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride are initially charged in polyethylene glycol dimethyl ether, potassium fluoride and tetraphenylphosphonium bromide as phase tranfer catalyst and sulfolane to produce 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl fluoride BAYER CROPSCIENCE AG (DE) 2010-05-11 US disclosed
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides BAYER CROPSCIENCE AG (DE) 2009-12-10 US disclosed
EP-1928839-B1 METHOD FOR THE PRODUCTION OF 5-FLUORO-1,3-DIALKYL-1H-PYRAZOL-4-CARBONYL FLUORIDES BAYER CROPSCIENCE AG (DE) 2008-12-31 EP disclosed
EP-1015402-B1 Method for producing compounds containing fluorine, in particular fluorobenzaldehydes and fluorobenzonitriles CLARIANT GMBH (DE) 2002-12-04 EP disclosed
EP-0958052-B1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS CLARIANT GMBH (DE) 2002-12-04 EP disclosed
EP-0878461-B1 Process for the preparation of 3,5-difluoroaniline CLARIANT GMBH (DE) 2002-04-10 EP disclosed
EP-1015402-A1 METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES Aventis Research & Technologies GmbH & Co. KG (DE) 2000-07-05 EP disclosed
EP-0958052-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS Aventis Research & Technologies GmbH & Co. KG (DE) 1999-11-24 EP disclosed
US-5965775-A HEATING 3,5-DIFLUOROCHLOROBENZENE WITH AMMONIA IN PRESENCE OF SOLVENT AND CATALYST COMPRISING COPPER COMPOUND AND ONE METAL SELECTED FROM GROUP CONSISTING OF COPPER, IRON, COBALT, NICKEL, MOLYBDENUM,CHROMIUM AND ZINC CLARIANT GMBH (DE) 1999-10-12 US disclosed
EP-0908443-A2 Process for the preparation of fluorinated aromatic compounds Clariant GmbH (DE) 1999-04-14 EP disclosed
WO-1999011588-A1 METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 1999-03-11 WO disclosed
EP-0878461-A2 Process for the preparation of 3,5-difluoroaniline Clariant GmbH (DE) 1998-11-18 EP disclosed
WO-1998032532-A1 AMIDOPHOSPHONIUM-SALT-CONTAINING CATALYST FOR HALOGEN-FLUORINE EXCHANGE REACTIONS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 1998-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306401-A1 Method For The Production of 5-Fluoro-1,3-Dialkyl-1H-Pyrazol-4-Carbonyl Fluorides CYP4X1, DHX35, AOX1 DNM1 793/4885CA12 2159/4885CA1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.